Lea Partners has invested an undisclosed eight-digit euro sum in corporate performance-management software developer IDL for a majority stake.
New and historical backers invest in Belgium-based Imcyse, a developer of immunotherapies
Ergon uses its Ergon Capital Partners IV vehicle, which closed on €580m in March 2019
Buyout of the baking product company is the GP's fifth UK deal since opening a Manchester office
Sale ends an eight-year holding period for the GP, which owned an 83.4% stake in the company